Chemoinformaics analysis of Cyclohexene, 4-propyl-
| Molecular Weight | 124.227 | nRot | 2 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 6 |
| Exact Molecular Weight | 124.125 | nRing | 1 |
| Solubility: LogS | -3.976 | nHRing | 0 |
| Solubility: LogP | 4.158 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 25.6987 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.496 |
| Synth | 2.893 |
| Natural Product Likeliness | 0.727 |
| NR-PPAR-gamma | 0.023 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.007 |
| HIA | 0.003 |
| CACO-2 | -4.294 |
| MDCK | 0.0000251 |
| BBB | 0.859 |
| PPB | 0.947972 |
| VDSS | 2.826 |
| FU | 0.0740083 |
| CYP1A2-inh | 0.942 |
| CYP1A2-sub | 0.512 |
| CYP2c19-inh | 0.373 |
| CYP2c19-sub | 0.543 |
| CYP2c9-inh | 0.167 |
| CYP2c9-sub | 0.817 |
| CYP2d6-inh | 0.093 |
| CYP2d6-sub | 0.739 |
| CYP3a4-inh | 0.124 |
| CYP3a4-sub | 0.126 |
| CL | 10.495 |
| T12 | 0.358 |
| hERG | 0.025 |
| Ames | 0.012 |
| ROA | 0.011 |
| SkinSen | 0.948 |
| Carcinogencity | 0.553 |
| EI | 0.992 |
| Respiratory | 0.197 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.934238 |